MAUDE Adverse Event Report: OREGON MANUFACTURING PLANT NATURALYTE 1251 1K 2.5CA 1MG GAL; DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)

Model Number	08-1251-1
Medical Device Problem Code	Chemical Problem (2893)
Health Effect - Clinical Code	No Known Impact Or Consequence To Patient (2692)
Date of Event	10/28/2020
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
Event or Problem Description
A hemodialysis (hd) clinic biomedical technician (biomed) reported that a batch of naturalyte had low conductivity values during treatment.Upon follow up, the biomed reported that the conductivity was at 12.9 ms/cm.The biomed reported that the patient completed treatment with this product.The patient did not develop any symptoms, adverse events, injuries, or require medical intervention as a result of the reported event.Per biomed 15 cases were affected, and they are using naturalyte lot number 20ltac081 without any issues.The biomed reported that there has not been any service of repairs to the machines and they use naturalyte 45x bicarbonate lot number 20ktbc004.A return goods authorization (rga) was issued to the clinic to return a sample for evaluation.
Additional Manufacturer Narrative
Plant investigation: a product history review was performed.A review of the complaint management system identified 5 additional complaints related to conductivity issues with the reported lot.A review of the product inventory records for lot no.Indicated that 2195 cases of finished product were manufactured for distribution with no noted nonconformances.After reviewing the finished product release summary, it was determined that 20lxac098 met release specifications.As of 11/20/2020 no samples were returned.Samples are not needed to confirm the allegation.Through other complaint allegations of the same issue for lots 20lxac056, 20lxac058, and 20lxac076, there were companion samples available for testing which were tested at both the oregon and irving laboratories and results were found to be conflicting.Due to the conflicting results found between the laboratories, the oregon test methods were reviewed and a deficiency was found in the test method pertaining to the sodium and potassium analyte tests.Because of the deficiency found in the test method, it was determined that lot 20lxac098 did not meet release specifications and the allegation conductivity low was confirmed.In conclusion, 20lxac098 release testing was found to be compromised due to the deficient test method.A non-conformance was opened for allegations of conductivity issues and escalated to a corrective action preventative action (capa).Based on the investigation performed, cause was traced to manufacturing.

• Brand Name: NATURALYTE 1251 1K 2.5CA 1MG GAL
• Common Device Name: DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
• Manufacturer (Section D): OREGON MANUFACTURING PLANT; director, quality systems; 750 n lallendorf road; oregon OH 43616
• MDR Report Key: 10932840
• Report Number: 3005162618-2020-00176
• Device Sequence Number: 3186152
• Product Code: KPO
• UDI-Device Identifier: 00840861101658
• UDI-Public: 00840861101658
• Combination Product (Y/N): N
• Initial Reporter Country: US
• PMA/510(K) Number: K192017
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: company representative
• Initial Reporter Occupation: Biomedical Engineer
• Type of Report: Initial,Followup
• Report Date (Section B): 12/29/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 09/30/2022
• Device Model Number: 08-1251-1
• Device Catalogue Number: 08-1251-1
• Device Lot Number: 20LXAC098
• Was Device Available for Evaluation?: No
• Device Age: MO
• Initial Date Received by Manufacturer: 11/06/2020
• Supplement Date Received by Manufacturer: 12/18/2020
• Initial Report FDA Received Date: 12/02/2020
• Supplement Report FDA Received Date: 12/29/2020
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1